# Eleftherios Mylonakis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eleftherios-mylonakis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,643 |
| Field | Antifungal resistance and susceptibility |
| h-index | 94 |
| i10-index | 376 |
| Last Known Institution | Houston Methodist |
| OpenAlex ID | https://openalex.org/A5011903299 |
| ORCID iD | https://orcid.org/0000-0002-4624-0777 |
| Works | 568 |

## Researcher papers

- [Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial](https://scholariq.org/papers/rezafungin-versus-caspofungin-for-treatment-of-candidaemia-and-invasive/)
- [Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial](https://scholariq.org/papers/tixagevimab-cilgavimab-for-treatment-of-patients-hospitalised-with-covid-19-a/)

## Researcher topics

- [Antifungal resistance and susceptibility](https://scholariq.org/topics/antifungal-resistance-and-susceptibility/)
- [Fungal Infections and Studies](https://scholariq.org/topics/fungal-infections-and-studies/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Antimicrobial Resistance in Staphylococcus](https://scholariq.org/topics/antimicrobial-resistance-in-staphylococcus/)
- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)

## Researcher university

- [Houston Methodist](https://scholariq.org/institutions/houston-methodist/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.